(Q35039119)

5 August 2017

1 reference

title

Formoterol delivered by Turbuhaler: in pediatric asthma (English)

1 reference

5 August 2017

1 reference

Susan M Cheer

1

1 reference

5 August 2017

Gregory T Warner

series ordinal

2

1 reference

5 August 2017

Stephanie E Easthope

series ordinal

3

1 reference

5 August 2017

publication date

1 January 2003

1 reference

5 August 2017

1 reference

5 August 2017

volume

5

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

63-8; discussion 69

1 reference

Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer.

5 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200305010-00008

Present and future treatment of asthma in infants and young children

21 January 2018

1 reference

12 December 2020

Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator

1 reference

12 December 2020

Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects

1 reference

12 December 2020

Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature

1 reference

12 December 2020

Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizerfi

1 reference

12 December 2020

Why are long-acting beta-adrenoceptor agonists long-acting?

1 reference

12 December 2020

Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children

1 reference

12 December 2020

Formoterol, a new long-acting selective beta 2-agonist, decreases airway responsiveness in children with asthma.

1 reference

12 December 2020

Cost-effectiveness of eformoterol Turbohaler versus salmeterol Accuhaler in children with symptomatic asthma

1 reference

12 December 2020

Childhood asthma: causes, epidemiological factors and complications

1 reference

12 December 2020

Formoterol via Turbuhaler gave better protection than terbutaline against repeated exercise challenge for up to 12 hours in children and adolescents

1 reference

12 December 2020

Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children

1 reference

12 December 2020

Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease

1 reference

12 December 2020

Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma

1 reference

12 December 2020

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

1 reference

12 December 2020

Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise-induced asthma in children

1 reference

12 December 2020

Exercise-induced asthma

1 reference

12 December 2020

10.2165/00128072-200305010-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1036221466

0 references

1 reference